The Anavex 2-73 Study

Do you or your loved one have Alzheimer’s Disease?

Are you interested in taking part in a clinical trial?

NeuroCentrix invites you to learn more about a clinical research study involving the use of a new investigational medication.

Who can take part?*

  • Aged 60-85
  • A diagnosis of early Alzheimer’s Disease
  • Availability of a study partner who spends at least 10 hours per week with the participant

What to expect

  • Study duration of approximately 48 weeks including 6 on-site visits
  • Study-related care, medical and cognitive assessments and study medication every 3 months

*Please note that there are additional criteria that must be met in order to qualify to participate in this study.

Interested to participate in a clinical trial?
Contact NeuroCentrix Research Team

Tell us how to contact you